Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2006 2
2008 2
2009 2
2011 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Effect of (-)-trans-PAT, a novel 5-HT2C receptor agonist, on intake of palatable food in mice.
Rowland NE, Crump EM, Nguyen N, Robertson K, Sun Z, Booth RG. Rowland NE, et al. Pharmacol Biochem Behav. 2008 Nov;91(1):176-80. doi: 10.1016/j.pbb.2008.07.004. Epub 2008 Jul 19. Pharmacol Biochem Behav. 2008. PMID: 18692085 Free PMC article.
(1R, 3S)-(-)-trans-PAT: a novel full-efficacy serotonin 5-HT2C receptor agonist with 5-HT2A and 5-HT2B receptor inverse agonist/antagonist activity.
Booth RG, Fang L, Huang Y, Wilczynski A, Sivendran S. Booth RG, et al. Eur J Pharmacol. 2009 Aug 1;615(1-3):1-9. doi: 10.1016/j.ejphar.2009.04.035. Epub 2009 May 3. Eur J Pharmacol. 2009. PMID: 19397907 Free PMC article.
Drug discovery targeting human 5-HT(2C) receptors: residues S3.36 and Y7.43 impact ligand-binding pocket structure via hydrogen bond formation.
Canal CE, Cordova-Sintjago TC, Villa NY, Fang LJ, Booth RG. Canal CE, et al. Eur J Pharmacol. 2011 Dec 30;673(1-3):1-12. doi: 10.1016/j.ejphar.2011.10.006. Epub 2011 Oct 12. Eur J Pharmacol. 2011. PMID: 22020288 Free PMC article.
Novel ligands for the human histamine H1 receptor: synthesis, pharmacology, and comparative molecular field analysis studies of 2-dimethylamino-5-(6)-phenyl-1,2,3,4-tetrahydronaphthalenes.
Ghoneim OM, Legere JA, Golbraikh A, Tropsha A, Booth RG. Ghoneim OM, et al. Bioorg Med Chem. 2006 Oct 1;14(19):6640-58. doi: 10.1016/j.bmc.2006.05.077. Epub 2006 Jun 16. Bioorg Med Chem. 2006. PMID: 16782354
Ligand-directed functional heterogeneity of histamine H1 receptors: novel dual-function ligands selectively activate and block H1-mediated phospholipase C and adenylyl cyclase signaling.
Moniri NH, Covington-Strachan D, Booth RG. Moniri NH, et al. J Pharmacol Exp Ther. 2004 Oct;311(1):274-81. doi: 10.1124/jpet.104.070086. Epub 2004 May 28. J Pharmacol Exp Ther. 2004. PMID: 15169829
Domain swapping in the human histamine H1 receptor.
Bakker RA, Dees G, Carrillo JJ, Booth RG, López-Gimenez JF, Milligan G, Strange PG, Leurs R. Bakker RA, et al. J Pharmacol Exp Ther. 2004 Oct;311(1):131-8. doi: 10.1124/jpet.104.067041. Epub 2004 May 24. J Pharmacol Exp Ther. 2004. PMID: 15159444
Molecular determinants of ligand-directed signaling for the histamine H1 receptor.
Booth RG, Fang L, Wilczynski A, Sivendren S, Sun Z, Travers S, Bruysters M, Sansuk K, Leurs R. Booth RG, et al. Inflamm Res. 2008;57 Suppl 1(0 1):S43-4. doi: 10.1007/s00011-007-0621-3. Inflamm Res. 2008. PMID: 18345497 Free PMC article. No abstract available.
Feedback